MS-associated astrocyte subpopulations are characterized by decreased NRF2 activation and increased MAFG activation, accompanied by elevated DNA methylation, GM-CSF signaling activation, and enhanced pro-inflammatory pathways. This evidence concerns the gene CSF2 and myeloid sarcoma.